Your browser is no longer supported. Please, upgrade your browser.
Settings
PTI Proteostasis Therapeutics, Inc. daily Stock Chart
PTI [NASD]
Proteostasis Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.29 Insider Own17.52% Shs Outstand54.59M Perf Week45.49%
Market Cap193.79M Forward P/E- EPS next Y-1.36 Insider Trans-11.84% Shs Float41.74M Perf Month306.60%
Income-64.20M PEG- EPS next Q-0.30 Inst Own42.80% Short Float2.77% Perf Quarter333.46%
Sales5.00M P/S38.76 EPS this Y31.30% Inst Trans-6.39% Short Ratio0.57 Perf Half Y251.49%
Book/sh1.37 P/B2.59 EPS next Y-11.50% ROA-55.90% Target Price7.00 Perf Year-28.71%
Cash/sh1.43 P/C2.49 EPS next 5Y- ROE-69.90% 52W Range0.61 - 5.80 Perf YTD9.57%
Dividend- P/FCF- EPS past 5Y-6.30% ROI-55.30% 52W High-38.79% Beta0.11
Dividend %- Quick Ratio6.90 Sales past 5Y20.00% Gross Margin- 52W Low481.97% ATR0.33
Employees48 Current Ratio6.90 Sales Q/Q- Oper. Margin- RSI (14)86.57 Volatility21.90% 16.52%
OptionableYes Debt/Eq0.00 EPS Q/Q50.00% Profit Margin- Rel Volume5.81 Prev Close3.79
ShortableYes LT Debt/Eq0.00 EarningsNov 05 Payout- Avg Volume2.03M Price3.55
Recom2.00 SMA20104.62% SMA50201.62% SMA200158.96% Volume10,841,323 Change-6.33%
Oct-18-18Upgrade RBC Capital Mkts Sector Perform → Outperform
Dec-12-17Reiterated Robert W. Baird Outperform $13 → $25
Apr-18-16Initiated Guggenheim Neutral
Mar-07-16Initiated Robert W. Baird Outperform $13
Mar-07-16Initiated RBC Capital Mkts Outperform $20
Mar-07-16Initiated Leerink Partners Outperform
Mar-07-16Initiated H.C. Wainwright Buy $15
Dec-03-19 07:00AM  Proteostasis Therapeutics to Present at the Piper Jaffray 31st Annual Healthcare Conference PR Newswire +10.00%
Dec-02-19 07:00AM  Proteostasis Therapeutics Regains Compliance with Nasdaq Listing Standards PR Newswire
Nov-29-19 12:15PM  Biotech Tops in November: Best ETFs & Stocks Zacks
Nov-27-19 08:42AM  Are Options Traders Betting on a Big Move in Proteostasis Therapeutics (PTI) Stock? Zacks
Nov-14-19 01:31PM  Healthcare Drives Wall Street: 5 Soaring ETFs & Stocks Zacks
Nov-07-19 04:05PM  Proteostasis Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update PR Newswire
Nov-06-19 07:00AM  Proteostasis Therapeutics Announces Completion of Enrollment in Global Phase 2 Study in Cystic Fibrosis PR Newswire +14.87%
Nov-05-19 10:44AM  We're Keeping An Eye On Proteostasis Therapeutics's (NASDAQ:PTI) Cash Burn Rate Simply Wall St. -7.08%
Oct-29-19 10:33AM  Proteostasis Therapeutics (PTI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release Zacks
Oct-24-19 07:00AM  Proteostasis Therapeutics Announces Presentations Highlighting its CFTR Modulators at the North American Cystic Fibrosis Conference PR Newswire
Oct-21-19 07:00AM  Proteostasis Therapeutics to Host Cystic Fibrosis Summit on Disparity in Access to CFTR Modulators Based on Geography Featuring Members of the Cystic Fibrosis Community and Thought Leaders PR Newswire
Oct-02-19 09:29AM  Vertex Enters Into Collaboration With Privately-Held Ribometrix Zacks
Sep-26-19 07:00AM  Proteostasis Therapeutics to Present at the 2019 Cantor Global Healthcare Conference PR Newswire
Sep-20-19 01:22PM  Did Proteostasis Therapeutics, Inc. (NASDAQ:PTI) Insiders Buy Up More Shares? Simply Wall St.
Sep-19-19 04:05PM  Proteostasis Therapeutics Announces Presentation at the UK Cystic Fibrosis Conference PR Newswire
Aug-15-19 03:47PM  Could Proteostasis Therapeutics, Inc.'s (NASDAQ:PTI) Investor Composition Influence The Stock Price? Simply Wall St. -7.43%
Aug-07-19 06:05PM  Proteostasis Therapeutics (PTI) Reports Q2 Loss, Lags Revenue Estimates Zacks
04:05PM  Proteostasis Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update PR Newswire
10:30AM  Will Proteostasis Therapeutics (PTI) Report Negative Q2 Earnings? What You Should Know Zacks
Aug-01-19 09:21AM  Proteostasis (PTI) to Post Q2 Earnings: What's in Store? Zacks
Jul-25-19 07:00AM  Proteostasis Therapeutics Initiates Dosing in Global Phase 2 Study in Cystic Fibrosis PR Newswire
Jul-23-19 07:00AM  Proteostasis Therapeutics Announces Management Changes and Appointments PR Newswire
Jul-15-19 11:19AM  Is Proteostasis Therapeutics, Inc. (NASDAQ:PTI) Excessively Paying Its CEO? Simply Wall St.
Jun-14-19 01:38PM  How Proteostasis Therapeutics, Inc. (NASDAQ:PTI) Could Add Value To Your Portfolio Simply Wall St.
Jun-04-19 07:00AM  Proteostasis Therapeutics Receives Orphan Drug Designation in the EU for PTI-428 for the Treatment of Cystic Fibrosis PR Newswire
Jun-03-19 07:00AM  Proteostasis Therapeutics Announces Presentations and Hosts Educational Symposium at the 42nd European Cystic Fibrosis Conference PR Newswire +8.95%
May-31-19 08:25AM  Vertex Selects Triple Combo Regimen for Regulatory Submission Zacks
May-15-19 08:00AM  Proteostasis Therapeutics to Present at the 2019 RBC Capital Markets Global Healthcare Conference PR Newswire +5.56%
May-13-19 08:00AM  Proteostasis Therapeutics Appoints Dr. Badrul Chowdhury, Former FDA Director of Pulmonology, Allergy, and Rheumatology, to Board of Directors PR Newswire
May-08-19 08:55PM  Proteostasis Therapeutics (PTI) Reports Q1 Loss, Tops Revenue Estimates Zacks
07:47PM  Proteostasis: 1Q Earnings Snapshot Associated Press
05:15PM  Proteostasis Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update PR Newswire
May-07-19 10:47AM  Proteostasis (PTI) to Post Q1 Earnings: What's in Store? Zacks
May-02-19 11:04AM  Market Sentiment Around Loss-Making Proteostasis Therapeutics, Inc. (NASDAQ:PTI) Simply Wall St. -5.61%
May-01-19 10:32AM  Analysts Estimate Proteostasis Therapeutics (PTI) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-08-19 08:44AM  Implied Volatility Surging for Proteostasis Therapeutics (PTI) Stock Options Zacks
Mar-26-19 12:11PM  Proteostasis Plunges on Weak Data From Cystic Fibrosis Study Zacks +6.87%
12:09PM  Some Proteostasis Therapeutics (NASDAQ:PTI) Shareholders Have Taken A Painful 86% Share Price Drop Simply Wall St.
07:36AM  The Daily Biotech Pulse: Japanese Cheer For AbbVie, Myokardia Offering, CytomX CFO Departs Benzinga
Mar-25-19 04:20PM  Why Vertex's Grip On This Huge Sales Opportunity Now Looks Unbreakable Investor's Business Daily -67.81%
12:35PM  Proteostatis stock plunges on cystic fibrosis triple combo data American City Business Journals
10:42AM  Proteostasis Therapeutics's stock plunges to pace all decliners after results of CF treatment trial disappoint MarketWatch
07:00AM  Proteostasis Therapeutics Announces Broad New Dataset from Proprietary Combination and Add-On CFTR Modulator Studies in Cystic Fibrosis Patients PR Newswire
Mar-23-19 12:20PM  The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs Benzinga
Mar-07-19 08:40AM  Vertex's VX-445 Triple Combo Cystic Fibrosis Trials Succeed Zacks
07:00AM  Proteostasis Therapeutics Appoints David Arkowitz to Board of Directors PR Newswire
Feb-27-19 08:00AM  Proteostasis Selected to Join European Consortium to Pioneer Personalized Medicine in Cystic Fibrosis PR Newswire -5.29%
Feb-25-19 07:55AM  Detailed Research: Economic Perspectives on Novartis AG, Proteostasis Therapeutics, Williams-Sonoma, Magna International, YRC Worldwide, and Delek Logistics Partners What Drives Growth in Today's Competitive Landscape GlobeNewswire
Feb-20-19 07:00AM  Proteostasis Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference PR Newswire
Feb-12-19 09:00AM  Biotech Plays in the News You Should Know ACCESSWIRE
Feb-07-19 10:54AM  How Much Of Proteostasis Therapeutics, Inc. (NASDAQ:PTI) Do Institutions Own? Simply Wall St. -5.50%
09:00AM  Biotech Stocks Set to Pop ACCESSWIRE
Feb-06-19 12:15PM  4 Biotech Stocks Making Moves on Wednesday (2/6/19) ACCESSWIRE +5.14%
08:00AM  Proteostasis Therapeutics Appoints Emmanuel Dulac and Kim Drapkin to Board of Directors PR Newswire
Dec-21-18 12:25PM  These 4 Biotech Stocks Are Raising Eyebrows ACCESSWIRE
07:58AM  The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial Benzinga
Dec-20-18 04:30PM  Proteostasis Therapeutics Provides Clinical Enrollment Update PR Newswire -6.38%
10:35AM  How Many Insiders Bought Proteostasis Therapeutics, Inc. (NASDAQ:PTI) Shares? Simply Wall St.
Dec-19-18 08:50AM  Implied Volatility Surging for Proteostasis Therapeutics (PTI) Stock Options Zacks
05:37AM  Waltham's Eloxx aims to reach cystic fibrosis patients that Vertex can't American City Business Journals
Dec-17-18 02:09PM  This Week's Top Tech Earnings and Today's Trending Stocks: PTI & NBEV Zacks -7.07%
12:53PM  Biotech News: Proteostasis Therapeutics (PTI) Stock Soars on Genentech InvestorPlace
09:54AM  Proteostasis Therapeutics Rallies On Genentech Licensing Agreement Benzinga
07:00AM  Proteostasis Therapeutics Announces Global License Agreement with Genentech PR Newswire
Nov-28-18 08:41AM  Vertex's (VRTX) Triple Combo Cystic Fibrosis Studies Succeed Zacks +9.22%
Nov-21-18 07:00AM  Proteostasis Therapeutics to Participate in Upcoming Investor Conferences PR Newswire
Nov-19-18 08:39AM  Is the Options Market Predicting a Spike in Proteostasis Therapeutics (PTI) Stock? Zacks
Nov-12-18 03:25PM  Proteostasis Therapeutics (PTI) Reports Q3 Loss, Tops Revenue Estimates Zacks -5.98%
Nov-06-18 10:30AM  Will Proteostasis Therapeutics (PTI) Report Negative Earnings Next Week? What You Should Know Zacks
Oct-26-18 09:15AM  Consolidated Research: 2018 Summary Expectations for Lexington Realty Trust, Proteostasis Therapeutics, PDC Energy, Twenty-First Century Fox, Square, and Sabra Healthcare REIT Fundamental Analysis, Key Performance Indications GlobeNewswire +11.96%
Oct-23-18 07:25PM  Proteostasis Therapeutics Prices Public Offering of Common Stock PR Newswire
08:35AM  The Daily Biotech Pulse: Regulus Soars On Positive Pre-Clinical Data, Biogen Earnings, Proteostasis And Eiger to Offer Shares Benzinga
Oct-22-18 04:01PM  Proteostasis Therapeutics Announces Proposed Public Offering of Common Stock PR Newswire -9.43%
01:56PM  5 Low-Priced Biotech Stocks to Take Advantage of the Market Rout InvestorPlace
Oct-19-18 05:41PM  Why Proteostasis Therapeutics Tumbled 23.2% on Friday Motley Fool -23.19%
03:20PM  Is Proteostasis Therapeutics Inc (NASDAQ:PTI) Worth US$10.35 Based On Intrinsic Value? Simply Wall St.
08:00AM  Todays Research Reports on Stocks to Watch: Proteostasis Therapeutics and Endocyte ACCESSWIRE
Oct-18-18 12:13PM  PTI Stock News: Why Is Proteostasis Therapeutics Stock Skyrocketing Today InvestorPlace +447.62%
11:15AM  Proteostasis Therapeutics Shares Surge On Positive Preliminary Cystic Fibrosis Trial Results Benzinga
10:57AM  Proteostasis Therapeutics' rockets to 4-fold gain on massive volume after positive trial results MarketWatch
07:56AM  The Daily Biotech Pulse: Novartis Buys Endocyte, Proteostasis Positive Cystic Fibrosis Trial, 2 IPOs Benzinga
Oct-17-18 04:05PM  Proteostasis Therapeutics Announces Positive Preliminary Results from Proprietary Doublet in Cystic Fibrosis Patients PR Newswire
Oct-05-18 08:33AM  Implied Volatility Surging for Proteostasis Therapeutics (PTI) Stock Options Zacks
Sep-28-18 07:30AM  Report: Exploring Fundamental Drivers Behind Ares Commercial Real Estate, Proteostasis Therapeutics, SunCoke Energy Partners, Fastenal, CNA Financial, and City Office REIT New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Sep-27-18 07:00AM  Proteostasis Therapeutics to Present at the Cantor Global Healthcare Conference PR Newswire -8.96%
Jun-25-18 07:00AM  Proteostasis Added to the Russell 3000® Index PR Newswire
Jun-08-18 08:00AM  Todays Research Reports on Stocks to Watch: Proteostasis Therapeutics and Ophthotech Corporation ACCESSWIRE
07:50AM  Proteostasis Therapeutics (PTI) Enters Oversold Territory Zacks
07:35AM  Analysis: Positioning to Benefit within Proteostasis Therapeutics, Yum China, Pretium Resources, Lexington Realty Trust, AngloGold Ashanti, and New Gold Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jun-07-18 04:52PM  More Data Needed On Proteostasis Therapeutics' Cystic Fibrosis Candidate, RBC Says In Downgrade Benzinga -38.16%
Jun-06-18 04:05PM  Proteostasis Announces Positive Data from Ongoing Phase 1 Study of PTI-801 in Cystic Fibrosis Patients on Background Orkambi® Therapy PR Newswire
Jun-04-18 07:20AM  Initiating Free Research Reports on Pulmatrix and Three Other Biotech Equities ACCESSWIRE
Jun-01-18 07:00AM  Proteostasis Announces Presentations at the 41st European Cystic Fibrosis Society Conference PR Newswire
May-31-18 07:00AM  Proteostasis Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference PR Newswire
May-08-18 07:00AM  Proteostasis Announces Formation of Independent Steering Committee of Leading Experts to Advise on the Global Phase 3 Clinical Development Program for PTI-428 in Cystic Fibrosis PR Newswire
Apr-24-18 12:32PM  Lifshitz & Miller LLP Announces Investigation of Acadia Pharmaceuticals Inc., Allegiant Travel Company, Camping World Holdings, Inc., Finish Line, Inc., Myriad Genetics, Inc., Proteostasis Therapeutics, Inc., Under Armour, Inc. and United Community Bancorp PR Newswire
Apr-17-18 07:10AM  Proteostasis Receives Endorsement from the Cystic Fibrosis Foundation's Therapeutic Development Network for the Study of the Company's Amplifier, PTI-428, in CF Subjects on Background Symdeko Therapy PR Newswire
Apr-16-18 08:40AM  Is the Options Market Predicting a Spike in Proteostasis Therapeutics (PTI) Stock? Zacks
Apr-06-18 07:00AM  Blog Exposure - FDA Granted Fast Track Designation to Proteostasis Therapeutics Triple Combination Program for Cystic Fibrosis ACCESSWIRE
Apr-04-18 08:29AM  Proteostasis shares surge 12% on FDA 'fast track' designation for cystic fibrosis treatment MarketWatch +6.52%
Proteostasis Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of various small molecule therapeutics to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing. The company's lead product candidates for the treatment of CF include PTI-801, a third generation cystic fibrosis transmembrane conductance regulator (CFTR) corrector agent; PTI-808, a CFTR potentiator; and PTI-428, a CFTR amplifier. It has collaboration agreements with Cystic Fibrosis Foundation, Inc. to research, develop, and commercialize products for the treatment of CF, non-classical CF, and other pulmonary diseases in the United States or the European Union; and Genentech, Inc. for licensing the technology and materials relating to therapeutic small molecule modulators. The company was formerly known as Proteoguard, Inc. and changed its name to Proteostasis Therapeutics, Inc. in September 2007. Proteostasis Therapeutics, Inc. was founded in 2006 and is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
New Enterprise Associates 12, 10% OwnerNov 27Sale2.521,166,7552,941,7394,270,691Nov 29 03:34 PM
New Enterprise Associates 12, 10% OwnerNov 26Sale2.45117,164287,1345,437,446Nov 29 03:34 PM
Munoz BenitoChief Scientific OfficerFeb 04Sale2.999,51428,45415,439Feb 05 08:04 PM
Lee Po ShunSee RemarksFeb 04Sale2.999,93129,70018,427Feb 05 08:00 PM
Gilmartin Geoffrey S.Chief Development OfficerFeb 04Sale2.999,18927,48014,911Feb 05 07:59 PM
Chhabra MeenuPresident and CEOFeb 04Sale2.9916,47849,30580,615Feb 05 07:57 PM
Lee Po ShunSee RemarksJan 29Sale3.007122,1362,312Jan 30 04:29 PM
Lee Po ShunSee RemarksJan 28Sale3.001,6004,8003,024Jan 30 04:29 PM